Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gilabert, J.
Right arrow Articles by Aznar, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gilabert, J.
Right arrow Articles by Aznar, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 10, No. suppl_2, pp. 121-131, 1995
© 1995 European Society of Human Reproduction and Embryology

Fibrinolytic system and reproductive process with special reference to fibrinolytic failure in pre-eclampsia

J. Gilabert1, A. Estellés2, S. Grancha2, F. España2 and J. Aznar3

Maternal Center, ‘La Fe’ University Hospital Valencia, Spain 2 Research Center ‘La Fe’ University Hospital Valencia, Spain 3 Department of Clinical Pathology, ‘La Fe’ University Hospital Valencia, Spain

Correspondence: 1Hospital Maternal y Centro de Investigación, Hospital La Fe, Avda de Campanar 21, 46009 Valencia, Spain

Here we summarize the recent progress in research on the role of the fibrinolytic system in reproduction, with a special emphasis on the role of the plasminogen activator inhibitors in fetal development. Trophoblasts produce fibrinolytic proteins that can promote normal implantation and regulate blood flow to the fetus and placenta throughout pregnancy. Normal pregnancy is associated with a hypofibrinolytic state that is fundamentally caused by an increase in plasminogen activator inhibitors types 1 and 2. In pre-eclampsia, a fibrinolytic failure, resulting from an increase in plasma and placental concentrations of plasminogen activator inhibitor-1, was observed. The localized elevated concentrations of placenta plasminogen activator inhibitor-1 protein and mRNA observed in pre-eclamptic patients would be expected to foster the deposition of fibrin and thus play a role in the complications associated with this disease. The decreased plasminogen activator inhibitor-2 concentrations in placenta and plasma from intrauterine fetal growth retardation pregnancies and the positive correlation between plasma/placenta plasminogen activator inhibitor-2 concentration and birthweight suggest that this inhibitor could be considered an adequate marker of placental function.

Key words: fibrinolysis/placenta/plasminogen activator inhibitors/pre-eclampsia/pregnancy/reproduction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
Y. Purwosunu, A. Sekizawa, K. Koide, A. Farina, N. Wibowo, G. H. Wiknjosastro, S. Okazaki, H. Chiba, and T. Okai
Cell-Free mRNA Concentrations of Plasminogen Activator Inhibitor-1 and Tissue-Type Plasminogen Activator Are Increased in the Plasma of Pregnant Women with Preeclampsia
Clin. Chem., March 1, 2007; 53(3): 399 - 404.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Y.-C. Ou, Y.-L. Kao, S.-L. Lai, F.-T. Kung, F.-J. Huang, S.-Y. Chang, and C.-C. ChangChien
Thromboembolism after ovarian stimulation: successful management of a woman with superior sagittal sinus thrombosis after IVF and embryo transfer: Case report
Hum. Reprod., November 1, 2003; 18(11): 2375 - 2381.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.